Charles Grummitt
Venture Partner at Medicxi
About
Charles Grummitt's Cambridge PhD in Protein Engineering plus hands-on experience building antibody discovery platforms at F-star and Adaptimmune makes him relevant to founders developing complex biologics and next-generation antibody formats.
Invests in
BiotechHealthtechMedical Devices
